49 computer-programmer-"https:"-"UCL" "https:" "https:" "https:" "https:" "https:" "https:" "P" "I.E" research jobs at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
Zamora-Gutierrez (https://www.southampton.ac.uk/people/65cf7s/doctor-veronica-zamora-gutierrez ). The position is fixed for 36 months (3 years). The postholder will lead research on bat ecology and the
-
the project forward and translate our research into tangible innovations for the UK’s growing photonics sector, building upon our recent work published in Nature (https://www.nature.com/articles/s41586-025
-
shaping contemporary political landscapes. Project Overview: Website: More information is available at the PLEDGE website: https://www.pledgeproject.eu/ ; Responsibilities: Engage in conceptual and
-
The Faculty of Medicine Genomic Informatics Group invites applications for a 3-year full time fixed-term postdoctoral position of Research Fellow or Senior Research Fellow in Genomic Informatics to
-
(field and laboratory), bioinformatics (e.g. metagenomics and high-performance computing), and handling plants and soil, particularly roots (i.e. rhizosphere collection and root traits). You will have a
-
Growth of Functional 1D and 2D Metal Dichalcogenide Semiconductors) Programme Grant recently announced by the UK Engineering and Physical Sciences Research Council (EPSRC). EXPRESS is a large (£10M
-
Precursors for the Electrochemical Growth of Functional 1D and 2D Metal Dichalcogenide Semiconductors) Programme Grant recently announced by the UK Engineering and Physical Sciences Research Council (EPSRC
-
visits. At the time of recruitment (i.e. first date of employment), you must not have resided or carried out your main activity (work, studies, etc…) in the UK for more than 12 months in the 3 years
-
programme, Deep Molecular Phenotyping of Metastatic Breast Cancer. This ambitious, interdisciplinary project aims to generate an integrated, multi-omic understanding of secondary (metastatic) breast cancer
-
postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML). This three-year project will harness cytotoxic